scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF01476215 |
P698 | PubMed publication ID | 4072781 |
P2093 | author name string | T Dóczi | |
P2860 | cites work | Use of Enhanced Computerized Tomography to Evaluate Osmotic Blood-Brain Barrier Disruption | Q34054848 |
Surgical risk as related to time of intervention in the repair of intracranial aneurysms | Q34236645 | ||
Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning | Q34285218 | ||
Experimentally induced cerebral aneurysms in rats: VII. Scanning electron microscope study | Q36660184 | ||
Computed tomography in aneurysmal subarachnoid haemorrhage | Q36999633 | ||
Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid haemorrhage | Q37045758 | ||
Computerized x-ray scanning of the brain | Q39323621 | ||
Intracerebral haemorrhage. Accuracy of computerised transverse axial scanning in predicting the underlying aetiology | Q39361712 | ||
Enhanced vesicular transport of exogenous peroxidase across cerebral vessels, induced by serotonin | Q39940113 | ||
Computed tomographic evaluation of hemorrhage secondary to intracranial aneurysm | Q39999553 | ||
Presidental address. Neuropathological aspects of brain edema | Q40045220 | ||
Computed tomography of hemorrhage from anterior communicating artery aneurysms, with angiographic correlation | Q40358965 | ||
The Normal Contrast-Enhanced Computed Axial Tomogram of the Brain | Q40685804 | ||
A specific immunofluorescence technique for the demonstration of vasogenic brain edema in paraffin embedded material | Q40987040 | ||
Recent ischemic brain infarcts at computed tomography: appearances pre- and postcontrast infusion | Q41967382 | ||
Disordered cerebro-vascular physiology in aneurysmal subarachnoid haemorrhage | Q42442028 | ||
Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes | Q42723636 | ||
Effect of an acute increase of the intravascular pressure on the blood-brain barrier: a comparison between conscious and anesthetized rats | Q43930111 | ||
Computed tomography and subarachnoid hemorrhage | Q44593411 | ||
Brain edema in acute arterial hypertension. I. Macroscopical findings | Q44920548 | ||
Cerebral vasospasm: a clinical observation | Q45037964 | ||
Quantitative determination of the permeability of the so-called blood-brain barrier of Evans blue (T 1824) | Q46576342 | ||
Computed tomography in the evaluation of intracranial aneurysms and subarachnoid hemorrhage | Q48302770 | ||
Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs | Q48302917 | ||
Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans | Q48302925 | ||
An extravascular component of contrast enhancement in cranial computed tomography. Part II. Contrast enhancement and the blood-tissue barrier | Q48427952 | ||
An extravascular component of contrast enhancement in cranial computed tomography. Part I. The tissue-blood ratio of contrast enhancement | Q48427959 | ||
cAMP-Mediated regulation of the permeability in the brain capillaries | Q48460386 | ||
Cerebral Energy Metabolism After Subarachnoid Hemorrhage | Q48489643 | ||
Relationship between cerebrospinal fluid and interstitial fluid of brain | Q48526534 | ||
Effect of experimental ischemia on cerebral water and electrolytes | Q48533052 | ||
Autoregulation of brain circulation in severe arterial hypertension | Q48672545 | ||
Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage | Q48684978 | ||
Blood-brain barrier in SAH. | Q48709594 | ||
An experimental study of the acute stage of subarachnoid hemorrhage | Q48710692 | ||
Intracranial pressure in patients with ruptured saccular aneurysm | Q48769103 | ||
The effect of transient cerebral ischemia on the vascular permeability to protein tracers | Q48855035 | ||
Blood-brain barrier changes after experimental subarachnoid haemorrhage. | Q49064108 | ||
The blood-brain barrier following experimental subarachnoid hemorrhage. Part 1: Response to insult caused by arterial hypertension. | Q50929861 | ||
The blood-brain barrier following experimental subarachnoid hemorrhage. Part 2: Response to mercuric chloride infusion. | Q50930036 | ||
THE PATHOGENESIS OF CEREBRAL INFARCTION FOLLOWING THE RUPTURE OF CEREBRAL BERRY ANEURYSMS | Q51271063 | ||
Relationship between contrast enhancement on computed tomography and cerebral vasospasm in patients with subarachnoid hemorrhage. | Q53806038 | ||
Changes in cerebral vasomotor reactivity to CO2 and autoregulation following experimental subarachnoid hemorrhage | Q54656590 | ||
Small animal model for investigation of subarachnoid hemorrhage and cerebral vasospasm | Q66968688 | ||
Blood-brain barrier opening to horseradish peroxidase in acute arterial hypertension | Q66969720 | ||
Extravasation of contrast-enhanced blood into the subarachnoid space during computed tomography | Q66975742 | ||
Computerized tomography and angiography in subarachnoid haemorrhage | Q67483501 | ||
Cerebral arterial blood flow and aneurysm surgery. Part 2: Induced hypotension and autoregulatory capacity | Q67716554 | ||
The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm | Q69553034 | ||
Contrast enhancement of cerebral infarcts. Incidence and clinical value in different states of cerebral infarction | Q70460515 | ||
Subarachnoid enhancement secondary to subarachnoid hemorrhage with special reference to the clinical significance and pathogenesis | Q70491545 | ||
[Computer tomographic findings in vascular malformations of the cerebral arteries (author's transl)] | Q70708361 | ||
Correlation between CT findings and subsequent development of cerebral infarction due to vasospasm in subarachnoid haemorrhage | Q70713960 | ||
A correlative study of computed tomography and histology in human and experimental vasogenic cerebral edema | Q70798378 | ||
Postcontrast computed tomography in subarachnoid hemorrhage from ruptured aneurysms | Q70798383 | ||
Transient disappearance of cerebral infarcts on CT scan, the so-called fogging effect | Q70982732 | ||
Grading of cerebral aneurysms and the timing of operation | Q70982822 | ||
A small animal model for electrocardiographic abnormalities observed after an experimental subarachnoid hemorrhage | Q71157062 | ||
Intravascular contrast injection in ischaemic lesions. II. Effect on prognosis | Q71248670 | ||
Significance of contrast enhancement in cranial computerized tomography after subarachnoid hemorrhage | Q71262086 | ||
Enhancement of cerebral infarcts with CT | Q71295782 | ||
Responses to experimental subarachnoid hemorrhage in the spontaneously breathing primate | Q71494848 | ||
P433 | issue | 3-4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pathogenesis | Q372016 |
blood–brain barrier | Q221694 | ||
P304 | page(s) | 110-132 | |
P577 | publication date | 1985-01-01 | |
P1433 | published in | Acta Neurochirurgica | Q15749688 |
P1476 | title | The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies | |
P478 | volume | 77 |
Q83708192 | 3% hypertonic saline following subarachnoid hemorrhage in rats |
Q57798989 | A Systematic Review of Cognitive Outcomes in Angiographically Negative Subarachnoid Haemorrhage |
Q34183079 | Astrocyte‐derived glutathione attenuates hemin‐induced apoptosis in cerebral microvascular cells |
Q40026519 | Bedside Xenon-CT Shows Lower CBF in SAH Patients with Impaired CBF Pressure Autoregulation as Defined by Pressure Reactivity Index (PRx). |
Q38952233 | Binaural blood flow control by astrocytes: listening to synapses and the vasculature. |
Q48504101 | Blood-brain barrier permeability change and regulation mechanism after subarachnoid hemorrhage |
Q71604485 | Brain energy metabolism in the acute stage of experimental subarachnoid haemorrhage: local changes in cerebral glucose utilization |
Q38172676 | Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management |
Q41045047 | Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats |
Q71370404 | Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin |
Q30310966 | Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation |
Q48903610 | Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage |
Q38169976 | Delayed neurological deterioration after subarachnoid haemorrhage |
Q64932967 | Early blood-brain barrier dysfunction predicts neurological outcome following aneurysmal subarachnoid hemorrhage. |
Q46039612 | Effects of melatonin in early brain injury following subarachnoid hemorrhage. |
Q50513796 | Effects of the radical scavenger AVS on behavioral and BBB changes after experimental subarachnoid hemorrhage |
Q89459645 | Endothelial Cell Dysfunction and Injury in Subarachnoid Hemorrhage |
Q47672113 | Erythropoietin in the cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage originates from the brain |
Q37099056 | Evaluating Permeability Surface-Area Product as a Measure of Blood-Brain Barrier Permeability in a Murine Model. |
Q37358330 | Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm |
Q34269672 | Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. |
Q48449404 | IL-33 expression in the cerebral cortex following experimental subarachnoid hemorrhage in rats |
Q53451584 | Immediate CT findings following embolization of cerebral aneurysms: suggestion of blood-brain barrier or vascular permeability change. |
Q28374437 | Immune abnormalities in aneurysmal subarachnoid haemorrhage patients: relation to delayed cerebral vasospasm |
Q50079390 | Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial Cells |
Q35056860 | Interleukin-1 and acute brain injury |
Q28287860 | Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study |
Q42321658 | Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice |
Q41941056 | Isoflurane on brain inflammation |
Q37810632 | Late cerebral ischaemia after subarachnoid haemorrhage: is cerebrovascular receptor upregulation the mechanism behind? |
Q34106377 | Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage |
Q34535638 | Mechanisms of acute brain injury after subarachnoid hemorrhage |
Q36398098 | Mechanisms of early brain injury after subarachnoid hemorrhage |
Q46742267 | Melatonin decreases mortality following severe subarachnoid hemorrhage |
Q36499334 | Molecular mechanisms of early brain injury after subarachnoid hemorrhage. |
Q37657438 | Necrostatin-1 reduces neurovascular injury after intracerebral hemorrhage. |
Q92702025 | Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential |
Q38005212 | New therapeutic approaches to subarachnoid hemorrhage |
Q74149371 | On the effect of calcium antagonists on cerebral blood flow in rats. A comparison of nimodipine and flunarizine |
Q38120761 | Pathophysiological Role of Global Cerebral Ischemia following Subarachnoid Hemorrhage: The Current Experimental Evidence |
Q88252100 | Permeability imaging as a predictor of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage |
Q38180668 | Plasticity of cerebrovascular smooth muscle cells after subarachnoid hemorrhage |
Q48025104 | Prolonged Intracisternal Papaverine Toxicity: Index Case Description and Proposed Mechanism of Action |
Q41181418 | Protective effect 3,4-dihydroxyphenylethanol in subarachnoid hemorrhage provoked oxidative neuropathy |
Q69436260 | Protective effect of experimental subarachnoid hemorrhage on sodium dehydrocholate-induced blood-brain barrier disruption |
Q52647371 | SIRT1 inhibition by sirtinol aggravates brain edema after experimental subarachnoid hemorrhage. |
Q48054847 | Spreading depolarizations in patients with spontaneous intracerebral hemorrhage: Association with perihematomal edema progression |
Q90688507 | Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial |
Q36723057 | Subarachnoid hemorrhage, spreading depolarizations and impaired neurovascular coupling |
Q93363336 | The Contractile Apparatus Is Essential for the Integrity of the Blood-Brain Barrier After Experimental Subarachnoid Hemorrhage |
Q64962416 | The Role of Glycerol-Containing Drugs in Cerebral Microdialysis: A Retrospective Study on the Effects of Intravenously Administered Glycerol. |
Q41834503 | The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage. |
Q27028040 | The importance of early brain injury after subarachnoid hemorrhage |
Q38213375 | The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. |
Q40029343 | The role of arterioles and the microcirculation in the development of vasospasm after aneurysmal SAH. |
Q37365666 | The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. |
Q64236955 | Thromboxane-prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats |
Q26825343 | Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage |
Q73011447 | Ultrastructural changes in the blood-brain barrier in rats after treatment with nimodipine and flunarizine. A comparison |
Q55362801 | Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage. |
Q52147985 | Vascular Endothelial Growth Factor in Brain Edema Formation After Subarachnoid Hemorrhage. |
Search more.